Investments
89Portfolio Exits
15Funds
3About Claremont Creek Ventures
Claremont Creek Ventures is a venture capital firm based in Oakland, California. The firm works closely with local institutions such as UC Berkeley, UC Davis, and the Lawrence Livermore and Berkeley Laboratories.
Claremont Creek Ventures Headquarters Location
300 Frank H. Ogawa Plaza Suite 350
Oakland, California, 94612,
United States
510-740-5001
Latest Claremont Creek Ventures News
Feb 6, 2019
DNAnexus, Inc. , the leader in biomedical informatics and data management, today announced closing a $68 million financing. The funds were raised from existing investors, GV (formerly Google Ventures), Foresite Capital, TPG Biotech , WuXi NextCODE, and Claremont Creek Ventures, as well as debt and equity financing from Innovatus Capital Partners, LLC. “DNAnexus has changed how global biomedical research and development markets manage their data and infrastructures,” commented Claes Ekstrom, Managing Director at Innovatus. “We are excited to support DNAnexus’ ongoing mission to accelerate science and medical discoveries by democratizing access to data through a global network.” The financing supports the deployment of DNAnexus Apollo ™, an advanced platform for multi-omics and clinical data exploration, analysis, and discovery. The Apollo Platform uses the DNAnexus global network, providing secure and compliant infrastructure with access to tools and datasets within a collaborative environment . DNAnexus supports some of the largest human genome sequencing projects in the world, including NIH’s All of Us , St. Jude Cloud , AstraZeneca’s 2-million genome initiative , and the Regeneron-Geisinger collaboration . “The financing enables further development of our translational research solutions, as well as continued growth in genomics with cloud-based solutions for research, clinical diagnostics, and clinical trials,” said Richard Daly, Chief Executive Officer at DNAnexus. “The next wave of biomedical insights will be derived from cross-institutional collaborations that generate massive volumes of clinical and multi-omics data. We are proud of our work dedicated to improving how global research and development organizations leverage large biomedical datasets to develop and deliver precision medicine solutions.” About DNAnexus DNAnexus, the leader in biomedical informatics and data management, has created the global network for genomics and other biomedical data, operating in 33 countries including North America, Europe, China, Australia, South America, and Africa. The secure, scalable, and collaborative DNAnexus Platform helps thousands of researchers across a spectrum of industries – biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia – accelerate their genomics programs. For more information on DNAnexus, please visit www.dnanexus.com or follow the company @DNAnexus. About Innovatus Capital Partners Innovatus adheres to an investment strategy that identifies disruptive and growth opportunities across multiple asset categories with a unifying theme of capital preservation, income generation, and upside optionality. The Firm has a dedicated team of life sciences investment professionals with deep experience in healthcare, including life sciences. Innovatus and its principals have significant experience providing debt financing to medical device, diagnostics, and biotechnology companies that address unmet medical needs, improve patient outcomes, and reduce overall healthcare expenditures. Further information can be found at innovatuscp.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20190206005088/en/ Media Contact:
Claremont Creek Ventures Investments
89 Investments
Claremont Creek Ventures has made 89 investments. Their latest investment was in Trove as part of their Series C on September 9, 2019.
Claremont Creek Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
9/26/2019 | Series C | Trove | $20M | No | 3 | |
2/6/2019 | Series F - II | DNAnexus | $68M | No | 3 | |
2/15/2018 | Series B | Trove | $12.57M | No | 3 | |
1/2/2018 | Series F | |||||
3/15/2017 | Unattributed |
Date | 9/26/2019 | 2/6/2019 | 2/15/2018 | 1/2/2018 | 3/15/2017 |
---|---|---|---|---|---|
Round | Series C | Series F - II | Series B | Series F | Unattributed |
Company | Trove | DNAnexus | Trove | ||
Amount | $20M | $68M | $12.57M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 3 | 3 | 3 |
Claremont Creek Ventures Portfolio Exits
15 Portfolio Exits
Claremont Creek Ventures has 15 portfolio exits. Their latest portfolio exit was Zipline Medical on December 31, 2019.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
12/31/2019 | Acquired | 1 | |||
8/19/2019 | Acquired | 2 | |||
6/13/2019 | Acquired | 1 | |||
Date | 12/31/2019 | 8/19/2019 | 6/13/2019 | ||
---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 | 2 | 1 |
Claremont Creek Ventures Fund History
3 Fund Histories
Claremont Creek Ventures has 3 funds, including Claremont Creek Ventures Fund II LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
10/2/2008 | Claremont Creek Ventures Fund II LP | Early-Stage Venture Capital | Closed | $175M | 1 |
11/18/2005 | Claremont Creek Ventures Fund I LP | ||||
Claremont Creek Ventures Fund III LP |
Closing Date | 10/2/2008 | 11/18/2005 | |
---|---|---|---|
Fund | Claremont Creek Ventures Fund II LP | Claremont Creek Ventures Fund I LP | Claremont Creek Ventures Fund III LP |
Fund Type | Early-Stage Venture Capital | ||
Status | Closed | ||
Amount | $175M | ||
Sources | 1 |
Claremont Creek Ventures Team
4 Team Members
Claremont Creek Ventures has 4 team members, including current Founder, Managing Director, Nathaniel Goldhaber.
Name | Work History | Title | Status |
---|---|---|---|
Nathaniel Goldhaber | CyberGold, Sun Microsystems, TopS Business Integrator, and Commonwealth of Pennsylvania | Founder, Managing Director | Current |
John Steuart | Founder | Current | |
Randall Hawks | Horizon Ventures, WHEB, Identix, Qume, and Texas Instruments | Managing Director | Current |
Greg Lahann | Alta Energy, ERP Power, and MK Global Ventures | Chief Financial Officer | Former |
Name | Nathaniel Goldhaber | John Steuart | Randall Hawks | Greg Lahann |
---|---|---|---|---|
Work History | CyberGold, Sun Microsystems, TopS Business Integrator, and Commonwealth of Pennsylvania | Horizon Ventures, WHEB, Identix, Qume, and Texas Instruments | Alta Energy, ERP Power, and MK Global Ventures | |
Title | Founder, Managing Director | Founder | Managing Director | Chief Financial Officer |
Status | Current | Current | Current | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.